DOI QR코드

DOI QR Code

Effects of Nardostachys Jatamansi on Atopic Dermatitis-like Skin Lesions

甘松香 (감송향)이 아토피樣 (양) 피부염에 미치는 영향

  • Min, Deul-Le (Department of Pediatrics, College of Oriental Medicine, Wonkwang University) ;
  • Park, Eun-Jung (Department of Pediatrics, College of Oriental Medicine, Wonkwang University)
  • 민들레 (원광대학교 한의과대학 소아과학교실) ;
  • 박은정 (원광대학교 한의과대학 소아과학교실)
  • Received : 2012.04.13
  • Accepted : 2012.05.21
  • Published : 2012.05.31

Abstract

Objectives NJ is being used to treat inflammatory diseases in Korea. In this study, we attempted to evaluate the effects of NJ on atopic dermatitis (AD)-like lesions and mast cell-mediated allergy inflammation in vivo and in vitro. Methods and Results We investigated to ascertain the pharmacological effects of NJ on 2,4-dinitrofluorobenzene (DNFB)-induced allergic reactions under in vivo conditions. Additionally, to find possible explanations for the anti-inflammatory mechanisms of NJ, we evaluated the regulatory effects of NJ on the level of inflammatory mediators in phorbol 12-myristate 13-acetate plus calcium ionophore A23187 (PMACI)-stimulated human mast cells (HMC-1). Conclusions NJ inhibited the production of the inflammatory cytokines (IgE, IL-6, IL-8 and TNF-${\alpha}$) significantly in vivo and in vitro.

Keywords

References

  1. Zhong Yao Da Ci Dian Pyeonchanwiwonhoe. Wanyeok Zhong Yao Da Ci Dian. Seoul: Jung Dam Publishing Co, 1997:53-7.
  2. The Korean Federation of Science and Technology Societies. A study on the international of indigenous technology in Korea: herb medicines. 1997.
  3. Shin MG. Imsangbonchohak. Seoul: Yeong Rim Sa Publishing Co, 2002:458-9.
  4. Kim CM, Shin MG, Ahn DG, Lee GS. Zhong Yao Da Ci Dian, Vol. 1. Seoul: Jung Dam Publishing Co, 1998:74-7.
  5. Hanuigwadaehak Bonchohak Pyeonchanwiwonhoe. Bonchohak. Seoul: Yeong Rim Sa Publishing Co, 2007:409-10.
  6. Guo Jia Zhong Yi Yao Guan Li Ju Zhong Hua Ben Cao Bian Wei Hui. Zhong Hua Ben Cao, Vol. 7. Shanghai: Shang Hai Ke Xue Ji Shu Publishing Co, 1999:564-6.
  7. Williams HC. Atopic dermatitis. Cambridge: Cambridge Univ Press, 2000:142-53.
  8. Daniels J, Harper J. The Epidemiology of Atopic Dermatitis. Hosp Med. 2002;63(11):649-52. https://doi.org/10.12968/hosp.2002.63.11.1908
  9. Hong CY. Pediatrics. Seoul: Daehane Textbook, 2004:1016-9.
  10. Hong WS. Jeonggyo Huang Di Nei Jing Su Wen. Seoul: Dong Yang Ui Hak Yeon Gu Won Press, 1985:72-80, 246-8.
  11. Song SG. Jin Gui Yao Lue Guang Zhou Xiao Quan. Beijing: Ren Min Wei Sheng Publishing Co, 1994:221-5.
  12. Chao YF. Chao Shi Zhu Bing Yuan Hou Lun. Seoul: Dae Sung Publishing Co, 1992:251-3.
  13. Kwon MW, Lee HJ, Park EJ, Hwang WJ. The Clinical Study of Atopic Dermatitis and Eosinophil Cationic Protein in Atopic Dermatitis. J Korean Orient Med. 2000;14(2):121-32.
  14. Cooper KD. Atopy Dermatitis: Recent Trends in Pathogenesis and Therapy. J Invest Dermatol. 1994;102(1):28-137. https://doi.org/10.1111/1523-1747.ep12388434
  15. Hanifin JM, Chan SC. Diagnosis and Treatment of Atopic Dermatitis. Management of Atopic Dermatitis: Current Status and Future Possibilities. Dermatologic Ther. 1996;1(1):9-18.
  16. Song JM. Inhibitory Effect of Nardostachys Chinensis BATAL. on Pancreatitis. Prof Grad School Orient Med Wonkwang Univ, 2009.
  17. Bae GS, Park HJ, Kim DY, Song JM, Kim TH, Oh HJ, Yun KJ, Park RK, Lee JH, Shin BC, Sim HJ, Hong SP, Song HJ, Park SJ. Nardostachys Jatamansi Protects against Cerulein-induced Acute Pancreatitis. Pancreas. 2010;39(4):520-9. https://doi.org/10.1097/MPA.0b013e3181bd93ce
  18. O KW, Jeong JH, Cheong HC, Cho HB, Kim SB, Choe CM. Inhibitory Effects of Nardostachys Jatamansi on the Maturation of Dendritic Cells. J Orient Obstet Gynecol. 2010;23(3):14-25.
  19. Bae GS, Seo SW, Kim MS, Park KC, Koo BS, Jung WS, Cho GH, Oh HC, Yun SW, Kim JJ, Kim SG, Hwang SY, Song HJ, Park SJ. Nardostachys Jatamansi Inhibits Lipopolysaccharide-induced Endotoxin Shock. J Nat Med. 2011;65(1):63-72. https://doi.org/10.1007/s11418-010-0458-x
  20. O JW, Kim GE, Pyeon BY, Lee HL, Jeong JT, Hong SJ, Park GS, Lee SY, Song SU, Kim CH, An GM, Nam SY, Shon MH, Kim WK, Lee MH, Kwon BC, Choi SY, Lee SY, Lee HB, Lee SI, Lee JS. Nationwide Study for Epidemiological Change of Atopic Dermatitis in School Aged Children between 1995 and 2000 and Kindergarten Aged Children in 2003 in Korea. Korean Acad Pediatr Allergy Respir Dis. 2003;13(4):227-37.
  21. Park YM. Advances in the Pathophysiology of Atopic Dermatitis. Korean Acad Pediatr Allergy Respir Dis. 2006;16(3):189-96.
  22. Korean Dermatological Association. Dermatology. Seoul: Ryo Moon Gak Publishing Co, 1994:133-8.
  23. The Korean Academy of Pediatric Allergy and Respiratory Disease. Pediatric allergy respiratology immunology. Seoul: Koonja Publisher, 2005:145-73.
  24. Lee JH, Kim KH, Kim MN, Kim JW, Ro YS, Park YL, Park CW, Lee KH, Lee AY, Cho SH, Choi JH. Report from ADRG: The Treatment Guideline of Korean Atopic Dermatitis. Korean J Dermatol. 2006;44(8):907-13.
  25. Cooper KD. New Therapeutic Approaches in Atopic Dermatitis. Clin Rev Allergy. 1993;11(4):543-59.
  26. Koo J, Arain S. Traditional Chinese Medicine for the Treatment of Dermatologic Disorders. Arch Dermatol. 1998;134:1388-93. https://doi.org/10.1001/archderm.134.11.1388
  27. Gao XK, Fuseda K, Shibata T, Tanaka H, Inagaki N, Nagai H. Kampo Medicines for Mite Antigen-induced Allergic Dermatitis in NC/Nga Mice. Evid Based Complement alternat Med. 2005;2(2):191-9. https://doi.org/10.1093/ecam/neh077
  28. Wu Q. Yi Zong Jin Jian, Vol. 3. Beijing: Ren Min Wei Sheng Publishing Co, 1982:443-4, 451-2.
  29. Zhong DY. Pibugwa Hanbangchiryo. Busan: Il Jung Sa Publishing Co, 1991:68-71.
  30. Jeong BR, Shin MG. Dohaehyangyakdaesajeon. Seoul: Yeong Rim Sa Publishing Co, 1990:932-4.
  31. Bose BC, Gupta SS, Bhatnagar JN, Vijayvargiya R. Nardostachys Jatamansi DC: Its Sedative and Depressant Action as Estimated by Warburg Technique. Indian J Med Sci. 1957;11(10):803-7.
  32. Salim S, Ahmad M, Zafar KS, Ahmad AS, Islam F. Protective Effect of Nardostachys Jatamansi in Rat Cerebral Ischemia. Pharmacol Biochem Behav. 2003;74:481-6. https://doi.org/10.1016/S0091-3057(02)01030-4
  33. Liu JH, Yin F, Zheng XX. Nardostachys Chinensis Glycoside Induces Characteristics of Neuronal Differentiation in Rat Pheochromocytoma PC12 Cells. Biol Pharm Bull. 2005;28(4):768-71. https://doi.org/10.1248/bpb.28.768
  34. Li P, Matsunaga K, Yamakuni T, Ohizumi Y. Nardosinone, the First Enhancer of Neurite Outgrowthpromoting Activity of Staurosporine and Dibutyryl Cyclic AMP in PC12D Cells. Brain Res Dev Brain Res. 2003;145(2):177-83. https://doi.org/10.1016/S0165-3806(03)00239-6
  35. Li P, Matsunaga K, Yamamoto K, Yoshikawa R, Kawashima K, Ohizumi Y. Nardosinone, a Novel Enhancer of Nerve Growth Factor in Neurite Outgrowth from PC12D Cells. Neurosci Lett. 1999;273(1):53-6. https://doi.org/10.1016/S0304-3940(99)00629-1
  36. Song MY, Bae UJ, Lee BH, Kwon KB, Seo EA, Park SJ, Kim MS, Song HJ, Kwon KS, Park JW, Ryu DG, Park BH. Nardostachys Jatamansi Extract Protects against Cytokine-induced ${\beta}$-cell Damage and Streptozotocin-induced Diabetes. World J Gastroenterol. 2010;16(26):3249-57. https://doi.org/10.3748/wjg.v16.i26.3249
  37. Lyle N, Gomes A, Sur T, Munshi S, Paul S, Chatterjee S, Bhattacharyya D. The role of antioxidant properties of Nardostachys Jatamansi in Alleviation of the Symptoms of the Chronic Fatigue Syndrome. Behav Brain Res. 2009;202(2):285-90. https://doi.org/10.1016/j.bbr.2009.04.005
  38. Lyle N, Bhattacharyya D, Sur TK, Munshi S, Paul S, Chatterjee S, Gomes A. Stress Modulating Antioxidant Effect of Nardostachys Jatamansi. Indian J Biochem biophys. 2009;46(1):93-8.
  39. Kumar VP, Chauhan NS, Padh H, Rajani M. Search for Antibacterial and Antifungal Agents from Selected Indian Medicinal Plants. J Ethnopharmacol. 2006;107(2):182-8. https://doi.org/10.1016/j.jep.2006.03.013
  40. Dhingra D. Goyal PK. Inhibition of MAO and GABA: Probable Mechanisms for Antidepressant-like Activity of Nardostachys Jatamansi DC. in Mice. Indian J Exp Biol. 2008;46(4):212-8.
  41. Joshi H, Parle M. Nardostachys Jatamansi Improves Learning and Memory in Mice. J Med Food. 2006;9(1):113-8. https://doi.org/10.1089/jmf.2006.9.113
  42. Salim S, Ahmad M, Zafar KS, Ahmad AS, Islam F. Protective Effect of Nardostachys Jatamansi in Rat Cerebral Ischemia. Pharmacol Biochem Behav. 2003;74(2):481-6. https://doi.org/10.1016/S0091-3057(02)01030-4
  43. Ali S, Ansari KA, Jafry MA, Kabeer H, Diwakar G. Nardostachys Jatamansi Protects against Liver Damage Induced by Thioacetamide in Rats. J Ethnopharmacol. 2000;71(3):359-63. https://doi.org/10.1016/S0378-8741(99)00153-1
  44. Gupta SS, Patel CB, Mathur VS. Effect of Nardostachys Jatamansi Fumes and Aerosols in Histamine-induced Bronchial Asthma in Guinea Pigs. J Indian Med Assoc. 1961;37:223-5.
  45. Lee J. Effect of Nardostachys Chinensis on the Apoptosis and Differentiation of HL-60 Cells. Prof Grad School Orient Med Wonkwang Univ, 2008.
  46. Bergstresser PR. Sensitization and Elicitation of Inflammation in Contact Dermatitis. Immunol Ser. 1989;46:219-45.
  47. Kimber I, Pichowski JS, Betts CJ, Cumberbatch M, Basketter DA, Dearman RJ. Alternative Approaches to the Identification and Characterization of Chemical Allergens. Toxicol In Vitro. 2001;15(4-5):307-12. https://doi.org/10.1016/S0887-2333(01)00027-3
  48. Lee KK, Kim JJ, Jung HJ, Jung SK. Effects of Cheongyeolyunbu-tang on the DNFB-induced Allergic Dermatitis. Korean J Orient Int Med. 2008;29(3):730-41.
  49. Kim SH, Choi JH, Kim JH, Park SY. Effect of Tang-gwi-eum-za- gagambang along with External Spray Therapy on the Spontaneously Occurring Atopic Dermatitis Development in NC/Nga Mouse. J Korean Orient Med Ophthalmol Otolaryngol Dermatol. 2005;18(1):27-49.
  50. Hong CH. Effects of Onchung-eum Administration along with Samhwangseze-gamibang on Treatment Atopic Dermatitis Development in NC/Nga Mice. Korean J Orient Physiol Pathol. 2007;21(3):679-87.
  51. Song SP. Effects of Danggwieumja Administration along with Samhwangseje-gamibang on NC/Nga Atopic Mice. Korean J Orient Physiol Pathol. 2007;21(5):1210-8.
  52. Baek YH. Salviae Miltiorrhizae Root Inhibits Atopic Dermatitis in the DNCB(dinitrochlorobenzene)-induced Atopic Dermatitis NC/Nga Mice. Grad School Orient Med Kyungwon Univ, 2006.
  53. Robinson DS, Larche M, Durham SR. Tregs and Allergic Disease. J Clin Invest. 2004;114:1389-1397. https://doi.org/10.1172/JCI200423595
  54. Corne J, Djukanovic R, Thomas L, Warner J, Botta L, Grandordy B, Gygax D, Heusser C, Patalano F, Richarson W, Kilchherr E, Staehelin T, Davis F, Gordon W, Sun L, Liou R, Wang G, Chang TW, Holgate S. The Effect of Intravenous Administration of a Chimeric Anti-IgE Antibody on Serum IgE Levels in Atopic Subjects: Efficacy, Safety, and Pharmacokinetics. J Clin Invest. 1997;99:879-87. https://doi.org/10.1172/JCI119252
  55. Ishizaka K. Regulation of IgE Synthesis. Ann Rev Imunol. 1984;2:159-82. https://doi.org/10.1146/annurev.iy.02.040184.001111
  56. Barnes PJ. Corticosteroids, IgE, and Atopy. J Clin Invest. 2001;107:265-6. https://doi.org/10.1172/JCI12157
  57. Mackaness GB. Delayed Hypersensitivity and the Mechanism of Cellular Resistance to Infection. In: Amos B. Progress in Immunology, First International Congress of Immunology. New York: Academic press. 1971:413.
  58. Moon PD, Na JJ, Jeong HJ, Hong SH, Kim SJ, Chae HJ, Kim HR, Choi JO, Lee SH, Shin JY, Kim HM. Inhibitory Effect of Gamibojungikaitang Extract on Mast cell-mediated Allergic Reaction in Murine Model. J Pharm Pharm Sci. 2005;8(1):94-101.
  59. Moller A, Lippert U, Lessmann D, Kolde G, Hamann K, Welker P, Schadendorf D, Rosenbach T, Luger T, Czarnetzki BM. Human Mast Cells Produce IL-8. J Immunol. 1993;151(6):3261-6.
  60. Ershler WB, Keller ET. Age-associated Increased Interleukin-6 Gene Expression, Late-life Diseases, and Frailty. Annu Rev Med. 2000;51:245-70. https://doi.org/10.1146/annurev.med.51.1.245
  61. Kim HM. Immunity & Allergy. Seoul: Shinil Books, 1998:159-73.
  62. Choi IY, Koo HN, Lee SH, Shin JY, Chae HJ, Kim HR, Kim CH, Hong SH, Kim HM. Anti-inflammatory Activity of Korean Folk Medicine 'Sabeksan'. Exp Mol Pathol. 2005;78(3):257-62. https://doi.org/10.1016/j.yexmp.2005.01.001
  63. Stankiewicz W, Dabrowski MP, Chcialowski A, Plusa T. Cellular and Cytokine Immunoregulation in Patients with Chronic Obstructive Pulmonary Disease and Bronchial Asthma. Mediators Inflamm. 2002;11(5):307-12. https://doi.org/10.1080/09629350210000015719

Cited by

  1. A Clinical Study on the Effect of Hwangryunhaedock-tang on Atopic Dermatitis vol.26, pp.4, 2012, https://doi.org/10.7778/jpkm.2012.26.4.051
  2. Medicinal Herb Extracts Attenuate 1-Chloro-2,4dinitrobenzene-induced Development of Atopic Dermatitis-like Skin Lesions vol.24, pp.8, 2014, https://doi.org/10.5352/JLS.2014.24.8.851
  3. Mice Through the AMP-Activated Protein Kinase Signaling Pathway vol.21, pp.4, 2018, https://doi.org/10.1089/jmf.2017.4015
  4. 아토피 피부염의 한의학적 치료에 대한 연구 동향 -대한한방소아과학회지를 중심으로- vol.31, pp.1, 2012, https://doi.org/10.7778/jpkm.2017.31.1.025
  5. Anti-inflammatory Effect of Nardostachys jatamansi on TNF-alpha-induced Inflammatory Response in HaCaT Cells vol.13, pp.4, 2012, https://doi.org/10.15810/jic.2017.13.4.003
  6. 감맥대조탕이 DNCB로 유발된 생쥐의 아토피피부염에 미치는 영향 vol.33, pp.2, 2012, https://doi.org/10.6114/jkood.2020.33.2.083
  7. Medicinal plants from the Himalayan region for potential novel antimicrobial and anti-inflammatory skin treatments vol.73, pp.7, 2012, https://doi.org/10.1093/jpp/rgab039